These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31827646)

  • 21. Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma.
    Yoshida K; Yokoi A; Matsuzaki J; Kato T; Ochiya T; Kajiyama H; Yamamoto Y
    Cancer Sci; 2021 Dec; 112(12):4977-4986. PubMed ID: 34618992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancer.
    Zhang Y; Roth JA; Yu H; Ye Y; Xie K; Zhao H; Chang DW; Huang M; Li H; Qu J; Wu X
    Carcinogenesis; 2019 Jul; 40(5):643-650. PubMed ID: 30428030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
    Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
    Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
    Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
    Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
    Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
    J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis.
    Zhang M; Zhao LJ; Liang WQ; Mao ZP
    Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNAs modulating glycolysis as non-invasive prognostic biomarkers of HNSCC.
    Avilés-Jurado FX; Muñoz C; Meler C; Flores JC; Gumà J; Benaiges E; Mora J; Camacho M; León X; Vilaseca I; Terra X
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1585-1594. PubMed ID: 32737645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis.
    Guraya S
    Int J Surg; 2018 Dec; 60():41-47. PubMed ID: 30336280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
    Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis.
    Fu X; Han Y; Wu Y; Zhu X; Lu X; Mao F; Wang X; He X; Zhao Y; Zhao Y
    Eur J Clin Invest; 2011 Nov; 41(11):1245-53. PubMed ID: 21521185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.
    Gao S; Zhao ZY; Zhang ZY; Zhang Y; Wu R
    Clin Transl Gastroenterol; 2018 Nov; 9(11):203. PubMed ID: 30420592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
    Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Zhan B; Lu D; Luo P; Wang B
    Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNAs in head and neck cancer: a scoping review of methods.
    Dharmawardana N; Ooi EH; Woods C; Hussey D
    Clin Exp Metastasis; 2019 Jun; 36(3):291-302. PubMed ID: 30877500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.